Detection of Aerosolized Mycobacterium tuberculosis DNA From Adults Being Investigated for Pulmonary Tuberculosis via an Electrostatic Sampler in a South African Primary Care Setting - Scorecard - MDSpire
Advertisement
Detection of Aerosolized Mycobacterium tuberculosis DNA From Adults Being Investigated for Pulmonary Tuberculosis via an Electrostatic Sampler in a South African Primary Care Setting
Clinical Scorecard: Detection of Mycobacterium tuberculosis DNA in Respiratory Aerosols from Adults Undergoing Evaluation for Pulmonary Tuberculosis Using an Electrostatic Sampler in a Primary Care Setting in South Africa
At a Glance
Category
Detail
Condition
Pulmonary Tuberculosis (TB)
Key Mechanisms
Detection of Mycobacterium tuberculosis DNA in cough-generated respiratory aerosols using an electrostatic air sampler (TB Hotspot Detector) combined with nucleic acid amplification testing (Xpert MTB/RIF Ultra).
Target Population
Symptomatic adults undergoing evaluation for pulmonary TB in primary care clinics in South Africa.
Care Setting
Primary health care clinics in South Africa.
Key Highlights
Electrostatic aerosol sampling using the TB Hotspot Detector is feasible and practical in primary care settings.
Aerosol Mtb DNA detection sensitivity was 46.6% overall and higher (56.9%) in participants with high sputum Ultra semiquantitative results.
Detection of aerosolized Mtb DNA correlates with infectiousness and may better predict transmission risk than sputum smear microscopy.
Guideline-Based Recommendations
Diagnosis
Consider aerosol sampling as a complementary diagnostic tool for pulmonary TB, especially in cases with sputum scarcity or to assess infectiousness.
Use nucleic acid amplification testing (Xpert MTB/RIF Ultra) on aerosol samples collected by electrostatic samplers for detection of Mtb DNA.
Management
Prioritize early diagnosis and identification of highly infectious TB cases to disrupt transmission cycles.
Exclude patients with recent hemoptysis or recent TB treatment from aerosol sampling to ensure safety and accuracy.
Monitoring & Follow-up
Monitor aerosol sampling device performance and environmental contamination to mitigate nosocomial transmission risks.
Assess sputum to aerosol Mtb DNA ratios to identify individuals with high capacity to expel infectious aerosols.
Risks
Potential nosocomial transmission risk due to aerosol sampling detected in 30% of environmental samples despite rigorous decontamination.
Risk of cough-induced hemoptysis necessitates exclusion of patients with recent hemoptysis from aerosol sampling.
Patient & Prescribing Data
Symptomatic adults presenting to primary care clinics with suspected pulmonary TB.
Aerosol Mtb DNA detection is more sensitive in males with medium or higher sputum Ultra semiquantitative results and may inform infectiousness and transmission risk.
Clinical Best Practices
Use portable, quiet, and compact electrostatic aerosol samplers (e.g., TB Hotspot Detector) for on-site collection of cough aerosols.
Collect at least two consecutive aerosol samples with participants coughing at least 10 times over 5 minutes in a dedicated sampling booth.
Implement rigorous environmental decontamination protocols to reduce contamination and nosocomial transmission risks.
Combine aerosol sampling results with sputum Ultra semiquantitative data to better assess infectiousness.
Exclude patients with recent hemoptysis or recent TB treatment to ensure safety and data validity.
by Jay Achar, Rouxjeane Venter, Jamie van Schalkwyk, Zandile Booi, Zama Mahlobo, Zaida Palmer, Nuno Rufino de Sousa, Knut Lönnroth, James A Seddon, Antonio Gigliotti Rothfuchs, Grant Theron
